The drug, Leqembi, may modestly slow cognitive decline in early stages of the disease but carries some safety risks. Still, data suggests it is more promising than the small number of other...
Federal Reserve officials, including Lisa Cook, a board member, are wrestling with how to think about price increases after 18 months of rapid change. » mehr lesen
In a call with investors on Thursday, the chief financial officer of Walgreens, James Kehoe, said “maybe we cried too much last year” over theft. » mehr lesen
Traders are betting that a slowdown in job growth and wage gains could reduce the pressure on prices and make the Federal Reserve less aggressive in raising interest rates. » mehr lesen
The Secure 2.0 Act provides for direct government contributions to retirement accounts for low- and moderate-income workers, though that won’t start until 2027. » mehr lesen
